LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Eikonizo Therapeutics…

Eikonizo Therapeutics Tech Stack

Eikonizo Therapeutics uses 8 technology products and services including Google Font API, Font Awesome, Flickity, and more. Explore Eikonizo Therapeutics's tech stack below.

  • Google Font API
    Font Scripts
  • Font Awesome
    Font Scripts
  • Flickity
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Priority Hints
    Performance
  • Lua
    Programming Languages
  • reCAPTCHA
    Security
  • OpenResty
    Web Servers

Eikonizo Therapeutics's Email Address Formats

Eikonizo Therapeutics uses at least 1 format(s):
Eikonizo Therapeutics Email FormatsExamplePercentage
First.Last@eikonizo.comJohn.Doe@eikonizo.com
48%
First.Middle@eikonizo.comJohn.Michael@eikonizo.com
2%
First.Last@eikonizo.comJohn.Doe@eikonizo.com
48%
First.Middle@eikonizo.comJohn.Michael@eikonizo.com
2%

Frequently Asked Questions

Where is Eikonizo Therapeutics's headquarters located?

Minus sign iconPlus sign iconEikonizo Therapeutics's main headquarters is located at 700 Main Street North Cambridge, MA 02139 US. The company has employees across 1 continents, including North America.

What is Eikonizo Therapeutics's official website and social media links?

Minus sign iconPlus sign iconEikonizo Therapeutics's official website is eikonizo.com and has social profiles on LinkedIn.

How much revenue does Eikonizo Therapeutics generate?

Minus sign iconPlus sign icon As of December 2023, Eikonizo Therapeutics's annual revenue reached $750K.

What is Eikonizo Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconEikonizo Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eikonizo Therapeutics have currently?

Minus sign iconPlus sign iconAs of December 2023, Eikonizo Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: R. F.Chief Scientific Officer: R. F.Head Of Operations: A. G.. Explore Eikonizo Therapeutics's employee directory with LeadIQ.

What industry does Eikonizo Therapeutics belong to?

Minus sign iconPlus sign iconEikonizo Therapeutics operates in the Biotechnology Research industry.

What technology does Eikonizo Therapeutics use?

Minus sign iconPlus sign iconEikonizo Therapeutics's tech stack includes Google Font APIFont AwesomeFlickityjQuery MigratePriority HintsLuareCAPTCHAOpenResty.

What is Eikonizo Therapeutics's email format?

Minus sign iconPlus sign iconEikonizo Therapeutics's email format typically follows the pattern of . Find more Eikonizo Therapeutics email formats with LeadIQ.

How much funding has Eikonizo Therapeutics raised to date?

Minus sign iconPlus sign icon As of December 2023, Eikonizo Therapeutics has raised $2M in funding. The last funding round occurred on Apr 17, 2018 for $2M.

When was Eikonizo Therapeutics founded?

Minus sign iconPlus sign iconEikonizo Therapeutics was founded in 2017.
Eikonizo Therapeutics

Eikonizo Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Our first program is focused on a disease-modifying therapeutic for neurodegenerative diseases.

Section iconCompany Overview

Headquarters
700 Main Street North Cambridge, MA 02139 US
Website
eikonizo.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $2M

    Eikonizo Therapeutics has raised a total of $2M of funding over 1 rounds. Their latest funding round was raised on Apr 17, 2018 in the amount of $2M.

  • $10M

    Eikonizo Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $2M

    Eikonizo Therapeutics has raised a total of $2M of funding over 1 rounds. Their latest funding round was raised on Apr 17, 2018 in the amount of $2M.

  • $10M

    Eikonizo Therapeutics's revenue is in the range of $10M

Company Leadership

  • Stylized image of a person
    R. F.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. F.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. G.
    Head Of Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. L.
    President & Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. H.
    Co-Founder
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    W. S.
    Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Evp, Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. G.
    Head Of Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. G.
    Vp Finance And Controller
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. H.
    Independent Director
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.